key: cord-0848917-mz3cvc0p
authors: Bone, A. E.; Finucane, A. M.; Leniz, J.; Higginson, I. J.; Sleeman, K. E.
title: Changing patterns of mortality during the COVID-19 pandemic: population-based modelling to understand palliative care implications
date: 2020-06-09
journal: nan
DOI: 10.1101/2020.06.07.20124693
sha: 346e03d9908e11e68c7a4d45e70d2e862ef1907a
doc_id: 848917
cord_uid: mz3cvc0p

Background COVID-19 has directly and indirectly caused high mortality worldwide. Aim To explore patterns of mortality during the COVID-19 pandemic and implications for palliative care provision, planning, and research. Design Descriptive analysis and population-based modelling of routine data. Participants and setting All deaths registered in England and Wales between 7th March and 15th May 2020. We described the following mortality categories by age, gender and place of death: 1) baseline deaths (deaths that would typically occur in a given period) 2) COVID-19 deaths 3) additional deaths not directly attributed to COVID-19. We estimated the proportion of COVID-19 deaths among people who would be in their last year of life in the absence of the pandemic, using simple modelling with explicit assumptions. Results During the first 10 weeks of the pandemic there were 101,615 baseline deaths, 41,105 COVID-19 deaths and 14,520 additional deaths. Deaths in care homes increased by 220% compared to home and hospital deaths which increased by 77% and 90%. Hospice deaths fell by 20%. Additional deaths were among older people (86% aged [≥]75 years), and most occurred in care homes (56%) and at home (43%). We estimate that 44% (38% to 50%) of COVID-19 deaths occurred among people who would have been in their last year of life in the absence of the pandemic. Conclusions Healthcare systems must ensure availability of palliative care to support people with severe COVID-19 in community and hospital settings. Integrated models of palliative care in care homes are urgently needed.

Approaches to death and dying reveal much of the attitude of society as a whole to the individuals who compose it (Cicely Saunders, 1984) . 1 The COVID-19 pandemic has led to an unprecedented surge in mortality around the world, with some countries such as United Kingdom (UK), the United States, and Italy particularly affected. In the UK and elsewhere the government response has been focused on prevention and curative treatments. There has been very little emphasis internationally on care needs, including palliative care needs, of people dying during the COVID-19 pandemic. 2 Clinical research and observation has found that people dying with COVID-19 are symptomatic, frequently experiencing breathlessness and agitation near the end of life. 3 Clinical uncertainty around the illness trajectories of those infected increases the complexity of clinical decision-making and communication with patients and family. 4 Deaths occurring during the COVID-19 pandemic are likely to be associated with poorer bereavement outcomes for family and friends and higher distress and support needs among frontline health and social care staff. 5 There is an important role for palliative care but these needs have not been described at a population level.

Large scale population-based studies exploring patterns of mortality are important for quantifying numbers in need of care, and for informing governments about the need to plan and reorganise services. In England and Wales, official mortality data from the Office for National Statistics (ONS) reveal that during the first 10 weeks of the pandemic, (7 th March to 15th May), there were over 41,000 COVID-19 deaths, most occurring in hospital (65%), with 28% in care homes and few elsewhere (7%). 6 The ONS estimated that there were also over 14,000 'additional' deaths which are deaths over and above the number of deaths expected based on the 5-year average, that were not certified as caused by . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 9, 2020. . https://doi.org /10.1101 /10. /2020 This study aims to explore patterns of mortality during the first 10 weeks of the COVID-19 pandemic in England and Wales (7 th March to 15 th May 2020) to understand implications for palliative care. The objectives are: 1) to explore trends in place of death; 2) to explore the age and gender distribution of baseline deaths, COVID-19 deaths and additional deaths; 3) to estimate the proportion of people who died from COVID-19 who would have been in their last year of life, and differences by age; 4) to use this information to discuss implications for palliative care provision, service planning, and research.

Descriptive analysis and population-based modelling using routinely collected mortality data for England and Wales.

We used publicly available data from the Office for National Statistics including:

• Weekly registered deaths in England and Wales by age group for 2015 to 2019.

• Weekly registered deaths in England and Wales in the weeks corresponding to the COVID-19 pandemic, between 7 th March (week 11) and 15 th May 2020 (week 20) 6 . This includes all deaths and COVID-19 deaths by age, gender and place of occurrence.

• Principal population projections of the total population of England and Wales by age for 2020 (2018-based) 7

We first defined the following mortality categories: baseline deaths, COVID-19 deaths and additional deaths, as detailed in Box 1.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted June 9, 2020. 

Deaths in excess of baseline deaths that are not accounted for by deaths certified as being as a direct result of COVID-19. This group might include deaths due to COVID-19 but not recorded as such, or deaths indirectly related to the pandemic for example through avoidance of hospital care.

The numbers of people in each mortality category were calculated for England and Wales between 7 th March and 15 th May 2020 as follows:

We estimated the baseline deaths according to the average deaths in the 10-week period of interest (weeks 11 to 20) over the years 2015 to 2019, by age and gender.

Data on COVID-19 deaths was obtained from the ONS weekly registered death, which includes deaths by age, gender and place of occurrence. 6 The ONS produce figures for deaths involving COVID-19, based on any mention of COVID-19 on the death certificate, including where the physician suspects COVID-19 based on symptoms but where no test was available. 6 These figures include deaths outside of hospital.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted June 9, 2020. . https://doi.org/10.1101/2020.06.07.20124693 doi: medRxiv preprint First, we derived an estimate of the proportion of the population infected in each age group, by re-arranging the following equation:

The information we used in this equation included the number of registered COVID-19 deaths reported by ONS 6 ; the total population from the ONS principal projections 7 ; and infection fatality ratios by 10-year age groupings obtained from Ferguson et al. Second, we hypothesised that someone who is in their last year of life will have an increased risk of dying from COVID-19 compared to someone in the same age group who is not in their last year of life. To account for this, we applied a risk of dying multiplier to this group based on evidence of increased risk of death among people with serious conditions (supplementary Table 2 ). 10 We applied a range of multipliers, with our primary estimate based on the median risk of death across different conditions. 10 Therefore, the number of people who die with COVID-19 who would be expected to die within a year was calculated using the following equation:

We calculated additional deaths by subtracting the estimated baseline deaths and COVID-19 deaths from all registered deaths on a per week basis over the 10-week period of interest (weeks 11 to 20). This was calculated for each age and gender group separately to identify additional deaths within different demographic categories. Where this resulted in a negative value, the estimated baseline figure was reduced by this amount and the value for additional deaths was zero.

Age, gender and place of death . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 9, 2020. . https://doi.org/10.1101/2020.06.07.20124693 doi: medRxiv preprint

To understand the age and gender distribution of the COVID-19 and additional deaths we grouped data into 4 age groups (<45, 45-64, 65-74, and >85 years) and compared them with baseline deaths over the period of interest (weeks 11 to 20). We described trends in place of occurrence of deaths, using the ONS defined categories of 'hospital' (acute and community, not psychiatric), 'care home' (nursing and residential), 'home', 'hospice' and combined 'other communal' and 'elsewhere'. To estimate additional deaths by place of death over the period, we used place of death data for week 11 to estimate baseline place of death, as weekly place of death information is unavailable for previous years.

We sought the views and experiences of members of our patient and public network regarding their concerns around COVID-19 pandemic (Johnson et al, 2020 submitted). 11 These consultations informed the focus and design of this study. A representative from the network provided feedback on the manuscript.

This study uses routinely collected anonymised and publicly available data. No ethical approvals were necessary.

Between 7 th March and 15 th May 2020 (weeks 11 to 20) in England and Wales there were 157,239 deaths of which 41,105 were from COVID-19. We estimate that this included 101,615 baseline deaths (as estimated by average weekly deaths over the same period during 2015-2019), and 14,520 additional deaths (Figure 1 ).

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 9, 2020. . https://doi.org/10.1101/2020.06.07.20124693 doi: medRxiv preprint

Where people die in England and Wales has changed ( Figure 2 ). Taking all deaths together, weekly hospital deaths increased by 90% from week 11 (n=4,975) to a peak in week 16 (n=9,434). We observe a 77% increase in home deaths between weeks 11 (n=2,725) and 17 (n=4834), while care home deaths increased by 220% during the same period (week 11 n=2,471, week 17 n= 7,911). In week 18, care homes temporarily became the most common place to die. Hospice deaths fell by 20% between weeks 11 (n=553) and week 19 (n=441), representing 3% of deaths during the 10 week period.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 9, 2020. . https://doi.org/10.1101/2020.06.07.20124693 doi: medRxiv preprint

Most COVID-19 deaths occurred in hospital (65%) and care homes (28%) with few occurring at home and hospice (5% and 1%). The location of the additional deaths has not been described. Comparing place of death for additional deaths occurring in weeks 12-20 with week 11, we found the majority of additional deaths occurred in care homes (56%) and at home (43%) (Figure 3 ). During weeks 12-20 there were fewer additional deaths in hospital and hospice compared to week 11, indicating that there were fewer non-COVID-19 deaths in these settings than usual.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 9, 2020. . https://doi.org/10.1101/2020.06.07.20124693 doi: medRxiv preprint 

We found the age distribution of COVID-19 deaths to be overall older compared to baseline deaths, with 74% of COVID-19 deaths aged >75 years compared to 68% of baseline deaths ( Figure 4 ). Additional deaths are older still, with 83% aged >75 years and 56% aged >85 years. A greater proportion of COVID-19 deaths are male (56%), compared to 49% of baseline deaths and 50% of additional deaths.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 9, 2020. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 9, 2020. 

Using routine data and modelling scenarios to understand mortality patterns during the COVID-19 pandemic, we highlight that care homes temporarily became the most common place to die in England and Wales, and that hospital and home deaths increased by over 50% while deaths in hospices fell by 20%. We show that people in the additional deaths category are proportionately more likely to be older, and to die in care homes and at home, than those who are certified as dying with COVID-19. Finally, we estimate for the first time that almost half of COVID-19 deaths occur among people who would be in their last year of life in the absence of the pandemic, and that this increases to two thirds of those aged over 85 years.

Deaths in hospitals, care homes and at home increased during the first weeks of the COVID-19 pandemic. Rapid adaptation of models of palliative care is needed to support the . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 9, 2020. . https://doi.org/10.1101/2020.06.07.20124693 doi: medRxiv preprint increased number of people dying in these settings. Guidance on remote consultations in primary care 12 and on managing distressing symptoms in the community 13 are available to help support care for people with suspected COVID-19, but challenges remain in terms of workforce and equipment. Specialist palliative care provision in care homes is currently variable, [14] [15] [16] and guidance to support palliative care for people with COVID-19 in nursing homes has been found to be lacking and limited in focus. 17 In contrast, deaths in hospices fell during the time period. A similar phenomenon was found during the 2003 SARS pandemic and highlighted the need for seamless continuity of care between settings. 18 Systems that enable hospice resources to be shifted from inpatient to community settings are likely to be important in future pandemic peaks. 19

Little has been described about the characteristics of the additional deaths that have occurred during the COVID-19 pandemic. The aetiology of these deaths is not known, in particular whether they are undiagnosed COVID-19 deaths, or deaths associated with the pandemic without being as a result of the disease (for example due to avoidance of urgent healthcare). 20 There is emerging evidence that older people with COVID-19 may present with non-specific and atypical symptoms such as delirium or low-grade fever. 21 We found that the additional deaths group comprises predominantly older people in care homes, suggesting that these may be undiagnosed COVID-19 deaths. Irrespective of aetiology, this group are likely to have significant palliative care needs. The characteristics of the additional deaths population is likely to change as the pandemic progresses and deferred harm from missed routine check-ups or screening becomes more likely. 22 At a population level we estimate that 44% of COVID-19 deaths occur among people who would have been in their last year of life in the absence of the pandemic, and that among those aged >85 years 66% are expected to be in their last year of life. For those with advanced conditions living at home and in care homes, guidelines recommend that general practitioners (GPs), community healthcare staff and community geriatricians urgently review . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 9, 2020. . https://doi.org/10.1101/2020.06.07.20124693 doi: medRxiv preprint advance care plans with patients, and discuss their care preferences in the case of contracting COVID-19. 13, 23 Our analysis indicates that this group is potentially very large and that enacting this recommendation will take significant resource.

While the focus of this paper is COVID-19, it should be noted that baseline deaths outnumber COVID-19 and additional deaths. Previous modelling has shown that around 69-82% of the baseline group are likely to have palliative care needs. 24 COVID-19 will impact on this group for example through fewer face to face contacts, and potentially less availability of specialist palliative care support as services are suddenly stretched beyond their usual bounds.

Across all mortality categories there is the need for bereavement support as a result of higher prevalence of complicated grief. 25 There will be the typical grief associated with death and dying, but on a much larger scale. In addition there will also be novel grief processes, linked to social isolation and distancing, self-blame around infection, and not being able to attend funerals. 26 Palliative care specialists with particular expertise in bereavement support have a role in supporting families in coping with bereavement, as well as and supporting colleagues to deliver this care alongside other relevant organisations.

This is the first paper to estimate and characterise population-level patterns of mortality during the COVID-19 pandemic in relation to palliative care. We have produced simple models with explicit assumptions to raise questions and stimulate discussion. We calculated additional deaths for each age and gender group separately to improve precision. However, this study has limitations. We have been limited by the available official data, including the lack of historical data on place of death by week in England and Wales. We have used data for England and Wales, and patterns are likely to vary by country and region, particularly with respect to care home deaths. The infection fatality ratio and risk of dying multipliers for . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 9, 2020. This study has focused on mortality only. Other aspects of palliative care that are important to consider, for example symptom control, support with difficult conversations, advance care planning, and complex clinical decision-making. 27 There are also longer-term needs among those surviving COVID-19, such as rehabilitation and palliative care, which are likely to be significant and important for service planning but were not modelled here. We have 

A population level understanding of the palliative care needs of people with severe COVID-19 is essential to guide efficient health service planning, but has been missing from political rhetoric around the world, much of which has been focused on intensive care capacity.

COVID-19 is now the focus of much research but very few studies are focused on palliative and end of life care. 29, 30 Data and research are urgently required to answer the following questions:

-What are the best integrated models of palliative care in care homes, that can be adapted for use during the COVID-19 pandemic?

-What is the impact of COVID-19 on the hospice sector and how might hospice services best use their available resources?

-What is the impact on the baseline group of the additional demand for palliative care?

-What is the symptom burden among people dying with COVID-19 in different settings?

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 9, 2020. -What will be the effect of COVID-19 on medium and long-term mortality projections and palliative care need?

Our study has highlighted the high level of need for palliative care during the COVID-19 pandemic. Healthcare systems responding to COVID-19 must consider the need for palliative care surge capacity, including the workforce and equipment to enable people to be cared for appropriately in all settings. The need for integrated models of palliative care in care home settings is imperative. The rapid changes to practice during the pandemic provide important opportunities for research, evaluation and learning and it is essential that new models are underpinned by evidence. We show that a high proportion of people who die with COVID-19 would be in their last year of life in the absence of the pandemic. While these data are estimates, and underlying assumptions may change, they highlight the need for careful consideration of the palliative care needs, in addition to intensive care needs, of people with severe COVID-19.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted June 9, 2020. Data sharing: All data is publicly available Ethical approval: Not required Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: no support from any organisation for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted June 9, 2020. . https://doi.org/10.1101/2020.06.07.20124693 doi: medRxiv preprint

World Health Organisation. Coronavirus disease (COVID-19) Pandemic

Characteristics, symptom management and outcomes of 101 patients with COVID-19 referred for hospital palliative care

The Importance of Addressing Advance Care Planning and Decisions About Do-Not-Resuscitate Orders During Novel Coronavirus 2019 (COVID-19)

Bereavement support on the frontline of COVID-19: Recommendations for hospital clinicians

The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China

Priorities for palliative care research during the COVID-19 pandemic: a rapid online stakeholder consultation with people affected by serious illness

National Institute for Health and Care Excellence. COVID-19 rapid guideline: managing symptoms (including at the end of life) in the community

Van den Block L, et al. Palliative care provision in long-term care facilities differs across Europe: Results of a cross-sectional study in six European countries (PACE)

Hospice utilization during the SARS outbreak in Taiwan

The role and response of palliative care and hospice services in epidemics and pandemics: a rapid review to inform practice during the COVID-19 pandemic

What is happening to non-covid deaths?

Atypical presentation of COVID-19 in a frail older person

National Institute for Health Research. Urgent Public Health COVID-19 Studies

UK Research and Innovation. COVID-19 research and innovation supported by UKRI